Literature DB >> 9038289

Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

C Marie1, C Fitting, C Cheval, M R Losser, J Carlet, D Payen, K Foster, J M Cavaillon.   

Abstract

In inflammatory and infectious diseases, the presence of circulating cytokines in plasma strongly suggests, following their exacerbated production, that saturation of specific binding sites has occurred or that an equilibrium between receptor-bound and free cytokines has been reached. In this report, we demonstrate that in addition to circulating interleukin-8 (IL-8), high levels of cell-associated IL-8 were detected in blood samples from patients with sepsis syndrome. The following analysis will reveal that in addition to erythrocytes, which have been dubbed a "sink" for IL-8, peripheral blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN) contributed to the detection of cell-associated IL-8. On a per cell basis, 2,000 to 7,000 times the amount of IL-8 was found associated with PMN than with erythrocytes. In addition, circulating cells may well be the source of the leukocyte-associated form of IL-8. Similarly, in vitro experiments, such as whole-blood stimulation assays or the addition of exogenous IL-8 in blood samples, demonstrated that a large proportion of the IL-8 was associated with leukocytes. This suggests that the trapping of free cytokines onto the cell surface and the internalization of the IL-8 bound to its receptor, occurring both in vitro and in vivo, allows the detection of this cell-associated form. This analysis of cell-associated cytokines was extended to IL-1ra, another component of the inflammatory response, which, in contrast to IL-8, has been demonstrated to exist as an intracellular form. Indeed, cell-associated IL-1ra was also detected in septic patients. The measurement of cell-associated proinflammatory and anti-inflammatory cytokines in patients is clearly a more reliable reflection of their production than is the simple measurement in plasma and may provide useful indication to further understand the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038289      PMCID: PMC175061     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Cell-associated IL-8 in human blood monocytes: analysis by flow cytometry.

Authors:  S Fujishima; H Nakamura; Y Waki; K Soejima; Y Takeuchi; M Ogawa; M Shiozawa; Y Hiraoka; T Kawashiro; S Aiso; M Kanazawa
Journal:  Cytometry       Date:  1996-08-01

2.  The production of TNF alpha and IL-8 in whole blood assays are differently regulated upon activation by LPS.

Authors:  J M Cavaillon; C Marie; C Pitton; C Fitting
Journal:  Prog Clin Biol Res       Date:  1995

Review 3.  Essential involvement of interleukin-8 (IL-8) in acute inflammation.

Authors:  A Harada; N Sekido; T Akahoshi; T Wada; N Mukaida; K Matsushima
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

4.  Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release.

Authors:  A C De Beaux; J P Maingay; J A Ross; K C Fearon; D C Carter
Journal:  J Interferon Cytokine Res       Date:  1995-05       Impact factor: 2.607

5.  Increased cell-associated IL-8 in human exudative and A23187-treated peripheral blood neutrophils.

Authors:  D B Kuhns; J I Gallin
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

6.  Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10.

Authors:  B Gesser; B Deleuran; M Lund; C Vestergård; N Lohse; M Deleuran; S L Jensen; S S Pedersen; K Thestrup-Pedersen; C G Larsen
Journal:  Biochem Biophys Res Commun       Date:  1995-05-25       Impact factor: 3.575

7.  Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis.

Authors:  H Nakamura; S Fujishima; Y Waki; T Urano; K Sayama; F Sakamaki; T Terashima; K Soejima; S Tasaka; A Ishizaka
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

8.  Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.

Authors:  A Chuntharapai; K J Kim
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

9.  Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes.

Authors:  A R Lloyd; A Biragyn; J A Johnston; D D Taub; L Xu; D Michiel; H Sprenger; J J Oppenheim; D J Kelvin
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

10.  IL-8 specifically binds to endothelial but not to smooth muscle cells.

Authors:  U Schönbeck; E Brandt; F Petersen; H D Flad; H Loppnow
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

View more
  13 in total

1.  Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus.

Authors:  C Riollet; P Rainard; B Poutrel
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis.

Authors:  Birgit Krausse-Opatz; Annette Busmann; Harald Tammen; Christoph Menzel; Thomas Möhring; Nicolas Le Yondre; Cornelia Schmidt; Peter Schulz-Knappe; Henning Zeidler; Hartmut Selle; Lars Köhler
Journal:  Med Microbiol Immunol       Date:  2007-01-06       Impact factor: 3.402

3.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

4.  Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

5.  Arginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activation.

Authors:  Herbert Bosshart; Michael Heinzelmann
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Induction of cell-associated chemokines after endotoxin administration to healthy humans.

Authors:  D P Olszyna; E De Jonge; P E Dekkers; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  OX40 induces CCL20 expression in the context of antigen stimulation: an expanding role of co-stimulatory molecules in chemotaxis.

Authors:  Wenwei Zhong; Zili Zhang; David Hinrichs; Xiumei Wu; Mark Hall; Zhenwei Xia; James T Rosenbaum
Journal:  Cytokine       Date:  2010-04-18       Impact factor: 3.861

8.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

9.  Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

Authors:  C Arnold Spek; Annelies Verbon; Hella Aberson; John P Pribble; Cathal J McElgunn; Terence Turner; Tim Axtelle; Jan Schouten; Tom Van Der Poll; Pieter H Reitsma
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

10.  Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis.

Authors:  Song Hui Jia; Yue Li; Jean Parodo; Andras Kapus; Lingzhi Fan; Ori D Rotstein; John C Marshall
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.